US 9796976
Methods and compositions for modulating alpha-1 antitrypsin expression
granted A61KA61K31/7115A61K31/712
Quick answer
US patent 9796976 (Methods and compositions for modulating alpha-1 antitrypsin expression) held by Ionis Pharmaceuticals, Inc. expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/7115, A61K31/712, A61K31/7125